PNH and aHUS Market

PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
PNH and aHUS Market contains market size and forecasts of PNH and aHUS in Global, including the following market information:
Global PNH and aHUS Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global PNH and aHUS market was valued at 5300.3 million in 2021 and is projected to reach US$ 8035.6 million by 2028, at a CAGR of 6.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Soliris Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PNH and aHUS include Alexion Pharmaceuticals, Alnylam Pharmaceuticals and Omeros Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the PNH and aHUS companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PNH and aHUS Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global PNH and aHUS Market Segment Percentages, by Type, 2021 (%)
Soliris
Ultomiris
Global PNH and aHUS Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global PNH and aHUS Market Segment Percentages, by Application, 2021 (%)
PNH
aHUS
Global PNH and aHUS Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global PNH and aHUS Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PNH and aHUS revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies PNH and aHUS revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alexion Pharmaceuticals
Alnylam Pharmaceuticals
Omeros Corporation